Literature DB >> 25792530

A randomized trial of unruptured brain arteriovenous malformations study: what impact on clinical care and therapeutic decision?

C Cognard.   

Abstract

Entities:  

Year:  2015        PMID： 25792530      PMCID： PMC7964317          DOI： 10.3174/ajnr.A4294

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  8 in total

1.  Randomised consent trials.

Authors:  M Zelen
Journal:  Lancet       Date:  1992-08-08       Impact factor: 79.321

Review 2.  Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy.

Authors:  Christian Stapf; Jay P Mohr; Jae H Choi; Andreas Hartmann; Henning Mast
Journal:  Curr Opin Neurol       Date:  2006-02       Impact factor: 5.710

3.  Predictors of hemorrhage in patients with untreated brain arteriovenous malformation.

Authors:  C Stapf; H Mast; R R Sciacca; J H Choi; A V Khaw; E S Connolly; J Pile-Spellman; J P Mohr
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

4.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

5.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer.

Authors:  K M Taylor; R G Margolese; C L Soskolne
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

6.  The New York Islands AVM Study: design, study progress, and initial results.

Authors:  C Stapf; H Mast; R R Sciacca; A Berenstein; P K Nelson; Y P Gobin; J Pile-Spellman; J P Mohr
Journal:  Stroke       Date:  2003-04-10       Impact factor: 7.914

7.  A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials.

Authors:  Jean Raymond; Tim E Darsaut; Andrew J Molyneux
Journal:  Trials       Date:  2011-03-04       Impact factor: 2.279

8.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321
  8 in total
  1 in total

1.  What neurointerventionists think about the treatment of unruptured brain arteriovenous malformations: the complexity of moving towards evidence-based treatment.

Authors:  Mayank Goyal; Johanna M Ospel; Nima Kashani; Adnan H Siddiqui; Ricardo Hanel; Mohammed Almekhlafi; René Chapot
Journal:  Neuroradiology       Date:  2020-04       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.